ClinicalTrials.Veeva

Menu

Oxidative Stress Markers in COPD

M

Minia University

Status

Completed

Conditions

Role of Oxidative Stress in COPD

Treatments

Other: oxidative stess markers

Study type

Observational

Funder types

Other

Identifiers

NCT04748887
oxidative stress

Details and patient eligibility

About

Background:Striking feature of Chronic obstructive pulmonary disease (COPD) is its inability to resolve after cigarette smoke exposure has ended, which has contributed to the possibility that the disease could also be driven by other endogenous causes, such as autoimmunity or chronic infection . Many of the pathogenetic pathways involved in COPD and its development tend to be driven by oxidative stress.

Enrollment

70 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 1-Forty subjects of COPD who are non-smokers or stopped smoking for more than 6 months Based on the Global Initiative for Chronic Obstructive Lung Disease guidelines, COPD was diagnosed.9 2- Thirty subjects of non smokers healthy control

Exclusion criteria

  • Patients of:

    1. Acute exacerbation, at the time of the study, of COPD.
    2. Any obvious abnormal lung parenchymal lesions.
    3. Lung cancer.
    4. Congestive heart failure.
    5. current smokers
    6. Drugs e.g anti-inflammatory , steroids ,analgesics, insulin , antineoplastic, antipsychotic drugs in the previous 2 weeks before the study.

Trial design

70 participants in 2 patient groups

nonsmokers copd cases ,
Description:
Fourty subjects of COPD who are non-smokers or stopped smoking for more than 6 months
Treatment:
Other: oxidative stess markers
non smokers healthy control
Description:
Thirty subjects of non smokers healthy control
Treatment:
Other: oxidative stess markers

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems